Moreover, m6A regulator HNRNPA2B1 was found to function as an oncogenic factor to accelerate esophageal cancer (ESCA) progression, and it might be a promising prognostic biomarker for ESCA (Guo et al., 2020). Here, HNRNPA2B1 is linked to esophageal cancer.